definition & classification of diabetes & pre-diabetes...
TRANSCRIPT
'diabetes mellitus' derives from:
Greek: 'diabetes' – “siphon” or “to pass through”
Latin: 'mellitus' – “honeyed” or “sweet”**
* Diagnosis and Classification of Diabetes Mellitus. ADA 2009.** http://science.jrank.org/pages/2044/Diabetes-Mellitus.html
History
1979 - National Diabetes Data Group (NDDG) :
Glycaemic values
Diagnostic criteria
Symptoms
FG ≥ 140 mg/dl , or
G2h OGTT – 75 g glucose ≥ 200 mg/dl
NDDG. Diabetes 1979;28:1039–1057W.H.O. 1980
Non-DM DM
FG ≥ 140 mg/dl
National Diabetes Data Group (NDDG) :
IGT – high risk of progression to DM
IFG < 140 mg/dl
G 2h OGTT = 140 - 200 mg/dl
Non-DM IGT DM
FG < 140 mg/dl
G2h OGTT = 140-200 mg/dl
1979
Expert Committee on theDiagnosis and Classification of DM
In 1997
G2h-OGTT is not “golden-standard” for DM !!!
FG – test for diagnostic ≥ 126 mg/dl
Practical
Low-cost
Reproducible
Re-focus on the relation
glycaemia–chronic complication
Diabetes Care 1997;20:1183–1197
1997 IFG = 110 – 125 mg/dl
IGT = G 2h OGTT = 140 - 200 mg/dl
2003
IFG = 100 – 125 mg/dl
Non-DM IGT DM
IFG = 110100
mg/dl BG ≥ 126 mg/dl
G-2h OGTT=140-200mg/dl
FG (a jeun)
≥ 126 mg/dl or
Glycaemia 2–h post OGTT
≥ 200 mg/dl or
Symptoms & glycaemia ≥200 mg/dl
Non-DM HG DM
IFG < 110100 mg/dl
FG ≥ 126 mg/dl
&2006
G-2h OGTT = 140-200 mg/dl
IFG IGT
DM
Dg. !?
Metabolic disorder of multiple aetiology characterized by
chronic hyperglycaemia
with disturbances of
carbohydrate, fat & protein metabolism
resulting from defects of
insulin secretion, insulin action, or a combination of both
Definition
DeFronzo RA. International Textbook of Diabetes Mellitus. 3rd ed. Chichester, West Sussex, Hoboken, NJ: John Wiley; 2004.
Criteria used for gluco-metabolic classification according to the WHO (1999), ADA (1997) & (2003)
Lars Ryden et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. EHJ (2007)
Other specific types of diabetes
Lars Ryden et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. EHJ (2007)
Disorders of glycaemia: aetiological types and clinical stages
Lars Ryden et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. EHJ (2007)
Aetiological classification of glycaemic disorders
Lars Ryden et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. EHJ (2007)
Conversion factors between plasma and other vehicles for glucose values
Lars Ryden et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. EHJ (2007)
* Postprandial measurements should be made 1-2 h after the beginning of the meal, generally peak levels in patients with diabetes.
Glycemic goals• HbA1c < 7.0%
• Preprandial capillary plasma glucose 70-130 mg/dl (3.9-7.2 mmol/l)
• Peak postprandial capillary plasma glucose < 180 mg/dl (< 10.0 mmol/l)*
• Key concepts in setting glycemic goals
• HbA1c is the primary target for glycemic control
• Goals should be individualized based on:
– duration of diabetes
– age/life expectancy
– comorbid conditions
– known CVD or advanced microvascular complications
– hypoglycemia unawareness
– individual patient considerations
• More or less stringent glycemic goals may be appropriate for individual patients
• Postprandial glucose may be targeted if HbA1c goals are not met despite reaching preprandial glucose goals
Glycemia – Chronic DM complications
Glycemic continuum
A1c: 4% - 5% - 5,5% - 6% - 6,5% - 7% - > 7% ......
Risk continuum
Role of the A1C assay in the diagnosis of DM
International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. DIABETES CARE (2009)
• The A1C assay is an accurate, precise measure of chronicglycemic levels and correlates well with the risk of diabetescomplications.
• Diabetes should be diagnosed when A1C is 6.5%.
• Diagnosis should be confirmed with a repeat A1C test.Confirmation is not required in symptomatic subjects withplasma glucose levels 200 mg/dl (11.1 mmol/l).
• A1C testing is indicated in children in whom diabetes issuspected but the classic symptoms and a casual plasmaglucose 200 mg/dl (11.1 mmol/l) are not found.
Role of the A1C assay in the diagnosis of DM
International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. DIABETES CARE (2009)
For the identification of those at high risk for diabetes:
• The risk for diabetes based on levels of glycemia is acontinuum; therefore, there is no lower glycemic thresholdat which risk clearly begins.
• The categorical clinical states pre-diabetes, IFG, and IGTfail to capture the continuum of risk
• Individuals with A1C levels below the threshold fordiabetes but 6.0% should receive preventive interventions.
• Individuals with A1C below this range may still be at riskand may also benefit from prevention efforts.
V high risk
DM - 10 x
DM
Retinopathy risk
A1c – “Risk classes”
Low risk
A1c: 4% - 5% - 5,5% - 6% - 6,5% - 7%
High risk
12-25%-5 y
+
HTG, HBP, Ob,
DM fam his
DM risk
HbA1c Level
Multivariate-
Adjusted Hazard
Ratio for
diagnosed
diabetes
< 5% 0.52 (0.40-0.69)
5% to < 5.5% 1.00 (reference)
5.5% to < 6% 1.86 (1.67-2.08)
6% to < 6.5% 4.48 (3.92-5.13)
≥ 6.5% 16.47 (14.22-19.08)
The Atherosclerosis Risk in Communities (ARIC) study
A1c 6.5% + Confirmation
Without confirmation – symptoms ( 200 mg/dl).
A1c = 6% - 6.5% - Very high risk
Prevention +++
A1c < 6% - risk related to other RF for DM
Prevention ++
2010
Gestational diabetes mellitus (GDM) - “any degree of glucose
intolerance with onset or first recognition during pregnancy”:
> week 24
symptoms
Gestational Diabetes Mellitus: an Opportunity to
Prevent Type 2 Diabetes and Cardiovascular Disease
in Young WomenGraziano Di Cianni et al. Women's Health. 2010;6(1):97-105
Cumulative incidence
in the first 5 years
HR CV ev = 1,71
- HBP, DLP, microalbuminuria,
- enhanced CVR profile,
- increased vessel stiffness,
- early abnormalities in diastolic function
- impaired cardiac autonomic function
Non-DM DM
Non-DM IGT DM
FG < 140 mg/dl G2h OGTT = 140-200 mg/dl
FG < 140 mg/dl
Non-DZ IGT DM
IFG = 110100
mg/dlFG ≥ 126 mg/dl G-2h OGTT = 140-200 mg/dl
A1c: 4% - 5% - 5,5% - 6% - 6,5% - 7% - > 7% ......